A hierarchical classification is proposed as follows: AML with mutated TP53 precedes AML with myelodysplasia-related gene mutations which, in turn, takes precedence over AML with myelodysplasia-related cytogenetic abnormalities [47]. This evidence concerns the gene TP53 and Myelodysplasia.